Gujarat based leading healthcare company, Lincoln Pharmaceuticals Ltd on 22nd October was awarded a patent by the government of India for its liquid Diclofenac Metered-Dose Rectal Spray (Diclofenac Rectal Spray), a drug solution for quick relief and faster recovery to patients suffering from pre and postoperative pain, gynaecological surgery and musculoskeletal disorders.

Managing Director of the company with its headquarters in Ahmedabad, Mahendra Patel said that the patent has been awarded by the Government of India for “A Novel Liquid Rectal Spray Dosage Form Containing Diclofenac and Its Pharmaceutically Active Salts”, as patent number - IN320894. This patent is valid for 20 years.

He said that the company has necessary approvals from Drug Controller General of India (DCGI) and planning to launch it in the Indian market by January 2020. The Company is also planning to apply for a Global Patent for this novel solution.Clinical Trials conducted suggest that Diclofenac Rectal Spray is highly effective in patients suffering from pre and postoperative pain, gynaecological surgery and musculoskeletal disorders such as muscular pain, pain associated with arthritis, acute pain in renal colic and mild body ache.

He said, ''We have developed this formulation with Diclofenac Sodium BP 25 pc W/V, each squirt delivers Diclofenac Sodium 50 mg, Non-steroidal Anti-inflammatory Agent (NSAIDs). Due to this innovation, now patients can get far better results by using Diclofenac Rectal Spray as compared to the existing Diclofenac Suppository available in the market. Diclofenac Rectal Suppository market is Rs. 20 crore in India and growing at 16% per annum. The company see huge export potential for this product and will start product registration in markets including African continents, Latin America and Southeast Asian markets and gradually expand to other markets.''

Notably Lincoln Pharmaceuticals Ltd has a strong R and D team including 30 plus scientists. It has filled 20 plus patent applications and has been awarded five patents so far. The company has developed 300 plus formulations in 15 plus therapeutic areas including anti-infectives, respiratory system, cardio & CNS, anti-bacterial, anti-diabetic, anti-malaria among others.